Research Using the NACC Database


Transitions and pharmaceutical use by CDR level in Alzheimers disease.

 
   Lead Investigator:    Eldon Spackman
   Institution      :    University of Washington
   E-Mail           :    spackman@u.washington.edu
   Proposal ID      :    78

Publications:
1 Bloudek, L, Spackman, E and Sullivan, SD A Comparison of Transitions between Health States and Institutionalization among AD Patients vs Non-AD Dementia Patients Using the NACC-UDS Database 2010 Abstract Value Health 13 A108-A109
PUBLISHED

2 Bloudek, LM, Spackman, DE, Veenstra, DL, and Sullivan, SD CDR State Transition Probabilities in Alzheimer's Disease with an without Cholinesterase Inhibitor Intervention in an Observational Cohort 2011 Journal Article J Alzheimers Dis 24 599-607
PUBLISHED

3 Spackman, DE, Kadiyala, S, Neumann, PJ, Veenstra, DL and Sullivan, SD Measuring Alzheimer disease progression with transition probabilities: Estimates from NACC-UDS 2012 Journal Article Curr Alzheimer Res 9 1050-1058
PUBLISHED

Proposal Description: